SCHEMBL4459734

SCHEMBL4459734

Oc1ccc2ccc(O)c(O)c2n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN22 Q9Y2R2 1/20 0.39
ALDH1A1 P00352 3/20 0.34
HPGD P15428 3/20 0.34
HSD17B10 Q99714 3/20 0.34
EGFR P00533 2/20 0.34
LMNA P02545 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
ALOX15 P16050 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
METAP2 P50579 2/20 0.34
KDM4E B2RXH2 2/20 0.34
PLAU P00749 1/20 0.34
NCF1 P14598 1/20 0.34
PRKD3 O94806 1/20 0.34
PRKCG P05129 1/20 0.34
PRKCB P05771 1/20 0.34
POLB P06746 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6844002 0.81 CCR1 (0.43) ALDH1A1HPGDHSD17B10LMNACYP1A2
SCHEMBL672744 0.73 METAP2 (0.63) ALDH1A1HPGDHSD17B10LMNACYP1A2
SCHEMBL30082244 0.73 METAP2 (0.63) ALDH1A1HPGDHSD17B10LMNACYP1A2
SCHEMBL16444064 0.71 METAP2 (0.61) ALDH1A1HPGDHSD17B10LMNACYP1A2
SCHEMBL8467827 0.71 METAP2 (0.61) ALDH1A1HPGDHSD17B10LMNACYP1A2
SCHEMBL6540982 0.71 METAP2 (0.61) ALDH1A1HPGDHSD17B10LMNACYP1A2
SCHEMBL1496246 0.71 METAP2 (0.61) ALDH1A1HPGDHSD17B10LMNACYP1A2
Ammonia Solution, Strong SCHEMBL3284067 0.71 METAP2 (0.61) ALDH1A1HPGDHSD17B10LMNACYP1A2
SCHEMBL413180 0.71 METAP2 (0.61) ALDH1A1HPGDHSD17B10LMNACYP1A2
SCHEMBL15442576 0.71 METAP2 (0.61) ALDH1A1HPGDHSD17B10LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009140215-A2 METHOD FOR TREATING DRUG-RESISTANT BACTERIAL AND OTHER INFECTIONS WITH CLIOQUINOL, PHANQUINONE, AND RELATED COMPOUNDS GERAGHTY, ERIN (US) 2009-11-19 WO claimed
US-20080207673-A1 Method for Treating Cancer, Coronary, Inflammatory and Macular Disease, Combining the Modulation of Zinc-and/or Copper Dependent Proteins XILINAS MICHEL 2008-08-28 US claimed
WO-2009140215-A2 METHOD FOR TREATING DRUG-RESISTANT BACTERIAL AND OTHER INFECTIONS WITH CLIOQUINOL, PHANQUINONE, AND RELATED COMPOUNDS GERAGHTY, ERIN (US) 2009-11-19 WO disclosed
US-20080207673-A1 Method for Treating Cancer, Coronary, Inflammatory and Macular Disease, Combining the Modulation of Zinc-and/or Copper Dependent Proteins XILINAS MICHEL 2008-08-28 US disclosed
WO-2006117660-A2 METHOD FOR TREATING CANCER, CORONARY, INFLAMMATORY AND MACULAR DISEASE, COMBINING THE MODULATION OF ZINC- AND/OR COPPER DEPENDENT PROTEINS CLIO PHARMACEUTICAL CORPORATION (US) 2006-11-09 WO disclosed